These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33494381)

  • 1. Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses.
    Yang Y; Shi W; Abiona OM; Nazzari A; Olia AS; Ou L; Phung E; Stephens T; Tsybovsky Y; Verardi R; Wang S; Werner A; Yap C; Ambrozak D; Bylund T; Liu T; Nguyen R; Wang L; Zhang B; Zhou T; Chuang GY; Graham BS; Mascola JR; Corbett KS; Kwong PD
    Vaccines (Basel); 2021 Jan; 9(2):. PubMed ID: 33494381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes.
    Yang Y; Kong WP; Liu C; Ruckwardt TJ; Tsybovsky Y; Wang L; Wang S; Biner DW; Chen M; Liu T; Merriam J; Olia AS; Ou L; Qiu Q; Shi W; Stephens T; Yang ES; Zhang B; Zhang Y; Zhou Q; Rawi R; Koup RA; Mascola JR; Kwong PD
    Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.
    Li T; Zheng Q; Yu H; Wu D; Xue W; Xiong H; Huang X; Nie M; Yue M; Rong R; Zhang S; Zhang Y; Wu Y; Wang S; Zha Z; Chen T; Deng T; Wang Y; Zhang T; Chen Y; Yuan Q; Zhao Q; Zhang J; Gu Y; Li S; Xia N
    Emerg Microbes Infect; 2020 Dec; 9(1):2076-2090. PubMed ID: 32897177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5.
    Wang Z; Zhang B; Ou L; Qiu Q; Wang L; Bylund T; Kong WP; Shi W; Tsybovsky Y; Wu L; Zhou Q; Chaudhary R; Choe M; Dickey TH; El Anbari M; Olia AS; Rawi R; Teng IT; Wang D; Wang S; Tolia NH; Zhou T; Kwong PD
    Vaccines (Basel); 2023 Dec; 12(1):. PubMed ID: 38250850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity.
    Fluckiger AC; Ontsouka B; Bozic J; Diress A; Ahmed T; Berthoud T; Tran A; Duque D; Liao M; McCluskie M; Diaz-Mitoma F; Anderson DE; Soare C
    Vaccine; 2021 Aug; 39(35):4988-5001. PubMed ID: 34304928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity.
    Olia AS; Tsybovsky Y; Chen SJ; Liu C; Nazzari AF; Ou L; Wang L; Kong WP; Leung K; Liu T; Stephens T; Teng IT; Wang S; Yang ES; Zhang B; Zhang Y; Zhou T; Mascola JR; Kwong PD
    J Biol Chem; 2021 Oct; 297(4):101127. PubMed ID: 34461095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein.
    McGinnes Cullen L; Schmidt MR; Kenward SA; Woodland RT; Morrison TG
    J Virol; 2015 Jul; 89(13):6835-47. PubMed ID: 25903340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery.
    Liu C; Wang L; Merriam JS; Shi W; Yang ES; Zhang Y; Chen M; Kong WP; Cheng C; Tsybovsky Y; Stephens T; Verardi R; Leung K; Stein C; Olia AS; Harris DR; Choe M; Zhang B; Graham BS; Kwong PD; Koup RA; Pegu A; Mascola JR
    NPJ Vaccines; 2023 Aug; 8(1):111. PubMed ID: 37553406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters.
    Liu X; Park HS; Matsuoka Y; Santos C; Yang L; Luongo C; Moore IN; Johnson RF; Garza NL; Zhang P; Lusso P; Best SM; Buchholz UJ; Le Nouën C
    bioRxiv; 2022 Dec; ():. PubMed ID: 36561185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.
    Lu M; Dravid P; Zhang Y; Trivedi S; Li A; Harder O; Kc M; Chaiwatpongsakorn S; Zani A; Kenney A; Zeng C; Cai C; Ye C; Liang X; Shimamura M; Liu SL; Mejias A; Ramilo O; Boyaka PN; Qiu J; Martinez-Sobrido L; Yount JS; Peeples ME; Kapoor A; Niewiesk S; Li J
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33688034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old mice.
    Pflumm D; Seidel A; Klein F; Groß R; Krutzke L; Kochanek S; Kroschel J; Münch J; Stifter K; Schirmbeck R
    Front Immunol; 2023; 14():1231274. PubMed ID: 37753087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera.
    Seephetdee C; Bhukhai K; Buasri N; Leelukkanaveera P; Lerdwattanasombat P; Manopwisedjaroen S; Phueakphud N; Kuhaudomlarp S; Olmedillas E; Saphire EO; Thitithanyanont A; Hongeng S; Wongtrakoongate P
    Antiviral Res; 2022 Aug; 204():105370. PubMed ID: 35772601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
    Blanco JCG; Fernando LR; Zhang W; Kamali A; Boukhvalova MS; McGinnes-Cullen L; Morrison TG
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
    Lien CE; Kuo TY; Lin YJ; Lian WC; Lin MY; Liu LT; Cheng J; Chou YC; Chen C
    Clin Infect Dis; 2022 Jun; 74(11):1899-1905. PubMed ID: 34739037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection.
    Pérez P; Lázaro-Frías A; Zamora C; Sánchez-Cordón PJ; Astorgano D; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2021; 12():824728. PubMed ID: 35154086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2.
    Seephetdee C; Buasri N; Bhukhai K; Srisanga K; Manopwisedjaroen S; Lertjintanakit S; Phueakphud N; Pakiranay C; Kangwanrangsan N; Srichatrapimuk S; Kirdlarp S; Sungkanuparph S; Chutipongtanate S; Thitithanyanont A; Hongeng S; Wongtrakoongate P
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice.
    Powell AE; Zhang K; Sanyal M; Tang S; Weidenbacher PA; Li S; Pham TD; Pak JE; Chiu W; Kim PS
    ACS Cent Sci; 2021 Jan; 7(1):183-199. PubMed ID: 33527087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice.
    Powell AE; Zhang K; Sanyal M; Tang S; Weidenbacher PA; Li S; Pham TD; Pak JE; Chiu W; Kim PS
    bioRxiv; 2020 Aug; ():. PubMed ID: 32869030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual.
    Seydoux E; Homad LJ; MacCamy AJ; Parks KR; Hurlburt NK; Jennewein MF; Akins NR; Stuart AB; Wan YH; Feng J; Nelson RE; Singh S; Cohen KW; McElrath MJ; Englund JA; Chu HY; Pancera M; McGuire AT; Stamatatos L
    bioRxiv; 2020 May; ():. PubMed ID: 32511342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.